open access: Pharmaceutical care for patients with breast and ovarian cancer - adverse drug events Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, February 08, 2012

open access: Pharmaceutical care for patients with breast and ovarian cancer - adverse drug events



Blogger's Note:  'tag' line includes breast cancer only; study included few ovarian cancer patients


Conclusions
 
In conclusion, our results suggest that pharmaceutical care for patients with breast and ovarian cancer is feasible and may have an impact on PROs as particularly indicated by significant improvements of the antiemetic response and patient satisfaction. 

Although there is no doubt that a higher awareness of drug-related problems is beneficial, final conclusions on the effectiveness of a new health care intervention can only be drawn when studied in a randomized trial. Therefore, our data may serve as a valuable basis for planning a large randomized multicenter trial.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.